Immunohistochemical demonstration of tumour associated antigens in carcinoma-in-situ of the testis.

Int J Androl

Dept. of Pathological-Anatomy, Herlev Hospital, University of Copenhagen, DK-2730 Herlev, DenmarkDept. of Pathological-Anatomy, Hvidovre Hospital, University of Copenhagen, DK-2650 Hvidovre, DenmarkTreponematoses Department, Statens Seruminstitut, Amager Boulevard 80, DK-2300 Copenhagen S.

Published: March 1981

Atypical germ cells or so-called carcinoma-in-situ of the testis are often found in the tissue adjacent to germ cell tumours. The present study was performed to investigate if tumour associated antigens demonstrated immunohistochemically in the tumours could also be demonstrated in the carcinoma-in-situ. Using indirect immunoperoxidase technique 39 orchidectomy specimens were examined for the presence of a series of antigens: alpha-foetoprotein (AFP), alpha -antitrypsin (A AT), human chorionic gonadotrophin (hCG). specific pregnancy β-glycoprotein (SP ), human placental lactogen (hPL), carcino-embryonic antigen (CEA) and ferritin (FER). FER was demonstrated in the atypical cells in 24/29 cases of carcinoma-in-situ of the testis. HCG was demonstrated in intratubular syncytiotrophoblast-like cells in one case and in atypical germ cells in another specimen. No staining reaction was found for the other antigens investigated Normal germinal epithelium and germinal epithelium in non-malignant pathological changes of the testis were never stained. These findings which indicate that FER may be a possible marker of carcinoma-in-situ of the testis is of utmost interest, however investigation of a larger series is mandatory.

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1365-2605.1981.tb00678.xDOI Listing

Publication Analysis

Top Keywords

carcinoma-in-situ testis
16
tumour associated
8
associated antigens
8
atypical germ
8
germ cells
8
germinal epithelium
8
carcinoma-in-situ
5
testis
5
immunohistochemical demonstration
4
demonstration tumour
4

Similar Publications

Adenocarcinoma of the rete testis: clinicopathological study of 18 cases with emphasis on MET amplification and a review of the literature.

Histopathology

December 2024

State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-Sen University Cancer Center, Guangzhou, China.

Background: Knowledge regarding adenocarcinoma of the rete testis (ACRT) is extremely limited due to its scarcity.

Methods And Results: This study enrolled 18 patients with ACRT from multiple institutions. Clinicopathological and immunohistochemical features were investigated, together with a comprehensive review of 95 previously reported cases.

View Article and Find Full Text PDF

Background: Undescended testes (UDT) is a condition where one or both testes is absent in the scrotum. The general age recommendation in which the treatment should be performed is before 18 months old due to the infertility risk and malignancy in later life. In post-pubertal UDT, the current guideline recommends orchiectomy; however, the strength rating of this recommendation is weak.

View Article and Find Full Text PDF

The combination of BRAF and MEK inhibitors demonstrated significant clinical benefit in patients with BRAF-mutant non-small cell lung cancer (NSCLC). However, the molecular mechanisms of acquired resistance to BRAF and MEK inhibition in NSCLC are still unknown. Herein, we report a case of a 76-year-old man with a history of smoking who was diagnosed with BRAF V600E-mutant lung adenocarcinoma (PD-L1 > 50%) and subsequently candidate to first-line therapy with pembrolizumab.

View Article and Find Full Text PDF

Contralateral Testicular Biopsy in Men with Testicular Cancer.

Eur Urol Focus

May 2024

Department of Urology, Uro-Oncology, Robot Assisted and Reconstructive Urologic Surgery, University of Cologne Faculty of Medicine and University Hospital Cologne, Cologne, Germany; Center for Integrated Oncology Köln-Bonn, Cologne, Germany.

Article Synopsis
  • - Testicular germ cell tumors (TGCTs) are rare, making up about 1% of new cancer diagnoses in men, with incidence rates ranging from 7 to 10 per 100,000 in Europe and North America.
  • - About 2-5% of men with TGCT have a risk of germ cell neoplasia in situ (GCNIS) in the other testicle, which can develop into cancer in over 50% of cases.
  • - The review explores whether routine biopsies of the healthy testicle should be done to check for GCNIS, emphasizing the need for treatment only if it improves patient outcomes without significantly affecting testicular function.
View Article and Find Full Text PDF
Article Synopsis
  • Nuclear protein testis (NUT) carcinoma is a rare and aggressive tumor linked to chromosomal rearrangements of the NUTM1 gene, mainly affecting areas like the head, neck, and lungs, and is rarely found in the oral cavity.
  • A study involved analyzing 111 tumor samples from different hospitals using immunohistochemistry (IHC), fluorescence in-situ hybridization (FISH), and RNA sequencing to detect NUT protein expression and genetic rearrangements.
  • The study identified NUT protein expression in 5 cases (4.5%) located in various oral areas, with genetic analyses revealing distinct rearrangement patterns, underscoring the need for accurate detection of NUT carcinoma to prevent misdiagnoses, particularly
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!